- Home
- SPI vs RDHL Comparison
SPI vs RDHL Comparison
Compare SPI & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPI
- RDHL
- Stock Information
- Founded
- SPI N/A
- RDHL 2009
- Country
- SPI United States
- RDHL Israel
- Employees
- SPI N/A
- RDHL N/A
- Industry
- SPI Semiconductors
- RDHL Biotechnology: Pharmaceutical Preparations
- Sector
- SPI Technology
- RDHL Health Care
- Exchange
- SPI Nasdaq
- RDHL Nasdaq
- Market Cap
- SPI 10.5M
- RDHL 11.2M
- IPO Year
- SPI N/A
- RDHL N/A
- Fundamental
- Price
- SPI $0.31
- RDHL $7.06
- Analyst Decision
- SPI Hold
- RDHL
- Analyst Count
- SPI 1
- RDHL 0
- Target Price
- SPI N/A
- RDHL N/A
- AVG Volume (30 Days)
- SPI 216.3K
- RDHL 14.3K
- Earning Date
- SPI 11-26-2024
- RDHL 11-19-2024
- Dividend Yield
- SPI N/A
- RDHL N/A
- EPS Growth
- SPI N/A
- RDHL N/A
- EPS
- SPI N/A
- RDHL N/A
- Revenue
- SPI $209,528,000.00
- RDHL $3,707,000.00
- Revenue This Year
- SPI $19.94
- RDHL $224.90
- Revenue Next Year
- SPI $24.15
- RDHL $82.69
- P/E Ratio
- SPI N/A
- RDHL N/A
- Revenue Growth
- SPI 22.29
- RDHL N/A
- 52 Week Low
- SPI $0.27
- RDHL $6.80
- 52 Week High
- SPI $1.26
- RDHL $82.00
- Technical
- Relative Strength Index (RSI)
- SPI 38.11
- RDHL 29.71
- Support Level
- SPI $0.30
- RDHL $7.98
- Resistance Level
- SPI $0.39
- RDHL $7.36
- Average True Range (ATR)
- SPI 0.04
- RDHL 0.37
- MACD
- SPI -0.01
- RDHL -0.12
- Stochastic Oscillator
- SPI 15.43
- RDHL 0.00
About SPI SPI Energy Co. Ltd.
SPI Energy Co Ltd offers photovoltaic solutions for business, residential, government, and utility customers and investors. The company provides a range of engineering, procurement, and construction services to third-party project developers. It is also engaged in the development, manufacture, and marketing of various PV modules. It procures PV modules and other equipment for project construction from independent suppliers and contract work to third-party EPC contractors in areas such as logistics, installation, construction, and supervision. The company's geographical segments are the United Kingdom, Australia, United States, Greece, Japan, and Italy, of which the majority of its revenue comes from Australia.
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.